Efficacy of ubrogepant for the treatment of migraine symptoms during the prodrome (premonitory phase): Results from the PRODROME trial

The requested reference [c9804f613a37778dc50fd8b73d99110f4a7e7206] no longer exists in our database. It has been replaced by the current reference: [28847d99c74d27bddc19cd39cd8978c59458d2b7]

Authors
Category Primary study
Conference17th European Headache Congress (EHC)
Year 2024
This article has no abstract
Epistemonikos ID: 6b538fd8a66723ea35c22ab5b5f96e63469114bd
First added on: Jan 31, 2026